US2011124911A1PendingUtilityA1

Semi-synthetic terephthalic acid via microorganisms that produce muconic acid

58
Assignee: BURK MARK JPriority: Aug 5, 2009Filed: Aug 5, 2010Published: May 26, 2011
Est. expiryAug 5, 2029(~3.1 yrs left)· nominal 20-yr term from priority
C12P 7/44C12Y 402/01002C12N 9/88
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides a non-naturally occurring microbial organism having a muconate pathway having at least one exogenous nucleic acid encoding a muconate pathway enzyme expressed in a sufficient amount to produce muconate. The muconate pathway including an enzyme selected from the group consisting of a beta-ketothiolase, a beta-ketoadipyl-CoA hydrolase, a beta-ketoadipyl-CoA transferase, a beta-ketoadipyl-CoA ligase, a 2-fumarylacetate reductase, a 2-fumarylacetate dehydrogenase, a trans-3-hydroxy-4-hexendioate dehydratase, a 2-fumarylacetate aminotransferase, a 2-fumarylacetate aminating oxidoreductase, a trans-3-amino-4-hexenoate deaminase, a beta-ketoadipate enol-lactone hydrolase, a muconolactone isomerase, a muconate cycloisomerase, a beta-ketoadipyl-CoA dehydrogenase, a 3-hydroxyadipyl-CoA dehydratase, a 2,3-dehydroadipyl-CoA transferase, a 2,3-dehydroadipyl-CoA hydrolase, a 2,3-dehydroadipyl-CoA ligase, a muconate reductase, a 2-maleylacetate reductase, a 2-maleylacetate dehydrogenase, a cis-3-hydroxy-4-hexendioate dehydratase, a 2-maleylacetate aminoatransferase, a 2-maleylacetate aminating oxidoreductase, a cis-3-amino-4-hexendioate deaminase, and a muconate cis/trans isomerase. Other muconate pathway enzymes also are provided. Additionally provided are methods of producing muconate.

Claims

exact text as granted — not AI-modified
1 . A non-naturally occurring microbial organism, comprising a microbial organism having a muconate pathway comprising at least one exogenous nucleic acid encoding a muconate pathway enzyme expressed in a sufficient amount to produce muconate, said muconate pathway comprising an enzyme selected from the group consisting of a beta-ketothiolase, a beta-ketoadipyl-CoA hydrolase, a beta-ketoadipyl-CoA transferase, a beta-ketoadipyl-CoA ligase, a 2-fumarylacetate reductase, a 2-fumarylacetate dehydrogenase, a trans-3-hydroxy-4-hexendioate dehydratase, a 2-fumarylacetate aminotransferase, a 2-fumarylacetate aminating oxidoreductase, a trans-3-amino-4-hexenoate deaminase, a beta-ketoadipate enol-lactone hydrolase, a muconolactone isomerase, a muconate cycloisomerase, a beta-ketoadipyl-CoA dehydrogenase, a 3-hydroxyadipyl-CoA dehydratase, a 2,3-dehydroadipyl-CoA transferase, a 2,3-dehydroadipyl-CoA hydrolase, a 2,3-dehydroadipyl-CoA ligase, a muconate reductase, a 2-maleylacetate reductase, a 2-maleylacetate dehydrogenase, a cis-3-hydroxy-4-hexendioate dehydratase, a 2-maleylacetate aminoatransferase, a 2-maleylacetate aminating oxidoreductase, a cis-3-amino-4-hexendioate deaminase, and a muconate cis/trans isomerase. 
     
     
         2 . The non-naturally occurring microbial organism of  claim 1 , wherein said muconate pathway comprises a set of muconate pathway enzymes, said set of muconate pathway enzymes selected from the group consisting of:
 A) (1) beta-ketothiolase, (2) an enzyme selected from beta-ketoadipyl-CoA hydrolase, beta-ketoadipyl-CoA transferase, and beta-ketoadipyl-CoA ligase, (3) beta-ketoadipate enol-lactone hydrolase, (4) muconolactone isomerase, (5) muconate cycloisomerase, and (6) a muconate cis/trans isomerase;   B) (1) beta-ketothiolase, (2) an enzyme selected from beta-ketoadipyl-CoA hydrolase, beta-ketoadipyl-CoA transferase and beta-ketoadipyl-CoA ligase, (3) 2-maleylacetate reductase, (4) 2-maleylacetate dehydrogenase, (5) cis-3-hydroxy-4-hexendioate dehydratase, and (6) muconate cis/trans isomerase;   C) (1) beta-ketothiolase, (2) an enzyme selected from beta-ketoadipyl-CoA hydrolase, beta-ketoadipyl-CoA transferase and beta-ketoadipyl-CoA ligase, (3) 2-maleylacetate reductase, (4) an enzyme selected from 2-maleylacetate aminotransferase and 2-maleylacetate aminating oxidoreductase, (5) cis-3-amino-4-hexenoate deaminase, and (6) muconate cis/trans isomerase;   D) (1) beta-ketothiolase, (2) beta-ketoadipyl-CoA dehydrogenase, (3) 3-hydroxyadipyl-CoA dehydratase, (4) an enzyme selected from 2,3-dehydroadipyl-CoA transferase, 2,3-dehydroadipyl-CoA hydrolase and 2,3-dehydroadipyl-CoA ligase, and (5) muconate reductase;   E) (1) beta-ketothiolase, (2) an enzyme selected from beta-ketoadipyl-CoA hydrolase, beta-ketoadipyl-CoA transferase and beta-ketoadipyl-CoA ligase, (3) 2-fumarylacetate reductase, (4) 2-fumarylacetate dehydrogenase, and (5) trans-3-hydroxy-4-hexendioate dehydratase;   F) (1) beta-ketothiolase, (2) an enzyme selected from beta-ketoadipyl-CoA hydrolase, beta-ketoadipyl-CoA transferase and beta-ketoadipyl-CoA ligase, (3) 2-fumarylacetate reductase, (4) an enzyme selected from 2-fumarylacetate aminotransferase and 2-fumarylacetate aminating oxidoreductase, and (5) trans-3-amino-4-hexenoate deaminase.   
     
     
         3 . The non-naturally occurring microbial organism of  claim 2 , wherein said microbial organism comprises two exogenous nucleic acids each encoding a muconate pathway enzyme. 
     
     
         4 . The non-naturally occurring microbial organism of  claim 2 , wherein said microbial organism comprises three exogenous nucleic acids each encoding a muconate pathway enzyme. 
     
     
         5 . The non-naturally occurring microbial organism of  claim 2 , wherein said microbial organism comprises four exogenous nucleic acids each encoding a muconate pathway enzyme. 
     
     
         6 . The non-naturally occurring microbial organism of  claim 2 , wherein said microbial organism comprises five exogenous nucleic acids each encoding a muconate pathway enzyme. 
     
     
         7 . The non-naturally occurring microbial organism of  claim 2 , wherein said microbial organism comprises six exogenous nucleic acids each encoding a muconate pathway enzyme. 
     
     
         8 . The non-naturally occurring microbial organism of  claim 1 , wherein said at least one exogenous nucleic acid is a heterologous nucleic acid. 
     
     
         9 . The non-naturally occurring microbial organism of  claim 1 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium. 
     
     
         10 . A method for producing muconate, comprising culturing the non-naturally occurring microbial organism according to  claim 1 , under conditions and for a sufficient period of time to produce muconate according to  claim 1 . 
     
     
         11 .- 18 . (canceled) 
     
     
         19 . A non-naturally occurring microbial organism, comprising a microbial organism having a muconate pathway comprising at least one exogenous nucleic acid encoding a muconate pathway enzyme expressed in a sufficient amount to produce muconate, said muconate pathway comprising an enzyme selected from the group consisting of a 4-hydroxy-2-ketovalerate aldolase, a 2-oxopentenoate hydratase, a 4-oxalocrotonate dehydrogenase, a 2-hydroxy-4-hexenedioate dehydratase, a 4-hydroxy-2-oxohexanedioate oxidoreductase, a 2,4-dihydroxyadipate dehydratase (acting on 2-hydroxy), a 2,4-dihydroxyadipate dehydratase (acting on 4-hydroxyl group) and a 3-hydroxy-4-hexenedioate dehydratase. 
     
     
         20 . The non-naturally occurring microbial organism of  claim 19 , wherein said muconate pathway comprises a set of muconate pathway enzymes, said set of muconate pathway enzymes selected from the group consisting of:
 A) (1) 4-hydroxy-2-ketovalerate aldolase, (2) 2-oxopentenoate hydratase, (3) 4-oxalocrotonate dehydrogenase, (4) 2-hydroxy-4-hexenedioate dehydratase;   B) (1) 4-hydroxy-2-ketovalerate aldolase, (2) 4-hydroxy-2-oxohexanedioate oxidoreductase, (3) 2,4-dihydroxyadipate dehydratase (acting on 2-hydroxy), (4) 3-hydroxy-4-hexenedioate dehydratase; and   C) (1) 4-hydroxy-2-ketovalerate aldolase, (2) 4-hydroxy-2-oxohexanedioate oxidoreductase, (3) 2,4-dihydroxyadipate dehydratase (acting on 4-hydroxyl group), (4) 2-hydroxy-4-hexenedioate dehydratase.   
     
     
         21 . The non-naturally occurring microbial organism of  claim 20 , wherein said microbial organism comprises two exogenous nucleic acids each encoding a muconate pathway enzyme. 
     
     
         22 . The non-naturally occurring microbial organism of  claim 20 , wherein said microbial organism comprises three exogenous nucleic acids each encoding a muconate pathway enzyme. 
     
     
         23 . The non-naturally occurring microbial organism of  claim 20 , wherein said microbial organism comprises four exogenous nucleic acids each encoding a muconate pathway enzyme. 
     
     
         24 . The non-naturally occurring microbial organism of  claim 19 , wherein said at least one exogenous nucleic acid is a heterologous nucleic acid. 
     
     
         25 . The non-naturally occurring microbial organism of  claim 19 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium. 
     
     
         26 . A method for producing muconate, comprising culturing the non-naturally occurring microbial organism according to  claim 19 , under conditions and for a sufficient period of time to produce muconate. 
     
     
         27 .- 32 . (canceled) 
     
     
         33 . A non-naturally occurring microbial organism, comprising a microbial organism having a muconate pathway comprising at least one exogenous nucleic acid encoding a muconate pathway enzyme expressed in a sufficient amount to produce muconate, said muconate pathway comprising an enzyme selected from the group consisting of an HODH aldolase, an OHED hydratase, an OHED decarboxylase, an HODH formate-lyase, an HODH dehydrogenase, an OHED formate-lyase, an OHED dehydrogenase, a 6-OHE dehydrogenase, a 3-hydroxyadipyl-CoA dehydratase, a 2,3-dehydroadipyl-CoA hydrolase, a 2,3-dehydroadipyl-CoA transferase, a 2,3-dehydroadipyl-CoA ligase, and a muconate reductase. 
     
     
         34 . The non-naturally occurring microbial organism of  claim 33 , wherein said muconate pathway comprises a set of muconate pathway enzymes, set of muconate pathway enzymes selected from the group consisting of:
 A) (1) HODH aldolase, (2) OHED hydratase, (3) OHED decarboxylase, (4) 6-OHE dehydrogenase, and (5) muconate reductase;   B) (1) HODH aldolase, (2) OHED hydratase, (3) an enzyme selected from OHED formate-lyase and OHED dehydrogenase, (4) an enzyme selected from 2,3-dehydroadipyl-CoA hydrolase, 2,3-dehydroadipyl-CoA transferase and 2,3-dehydroadipyl-CoA ligase, and (5) muconate reductase; and   C) (1) HODH aldolase, (2) an enzyme selected from HODH formate-lyase and HODH dehydrogenase, (3) 3-hydroxyadipyl-CoA dehydratase, (4) an enzyme selected from 2,3-dehydroadipyl-CoA hydrolase, 2,3-dehydroadipyl-CoA transferase and 2,3-dehydroadipyl-CoA ligase, and (5) muconate reductase   
     
     
         35 . The non-naturally occurring microbial organism of  claim 34 , wherein said microbial organism comprises two exogenous nucleic acids each encoding a muconate pathway enzyme. 
     
     
         36 . The non-naturally occurring microbial organism of  claim 34 , wherein said microbial organism comprises three exogenous nucleic acids each encoding a muconate pathway enzyme. 
     
     
         37 . The non-naturally occurring microbial organism of  claim 34 , wherein said microbial organism comprises four exogenous nucleic acids each encoding a muconate pathway enzyme. 
     
     
         38 . The non-naturally occurring microbial organism of  claim 34 , wherein said microbial organism comprises five exogenous nucleic acids each encoding a muconate pathway enzyme. 
     
     
         39 . The non-naturally occurring microbial organism of  claim 33 , wherein said at least one exogenous nucleic acid is a heterologous nucleic acid. 
     
     
         40 . The non-naturally occurring microbial organism of  claim 33 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium. 
     
     
         41 . A method for producing muconate, comprising culturing the non-naturally occurring microbial organism according to  claim 33 , under conditions and for a sufficient period of time to produce muconate. 
     
     
         42 .- 47 . (canceled) 
     
     
         48 . A non-naturally occurring microbial organism, comprising a microbial organism having a muconate pathway comprising at least one exogenous nucleic acid encoding a muconate pathway enzyme expressed in a sufficient amount to produce muconate, said muconate pathway comprising an enzyme selected from the group consisting of a lysine aminotransferase, a lysine aminating oxidoreductase, a 2-aminoadipate semialdehyde dehydrogenase, a 2-aminoadipate deaminase, a muconate reductase, a lysine-2,3-aminomutase, a 3,6-diaminohexanoate aminotransferase, a 3,6-diaminohexanoate aminating oxidoreductase, a 3-aminoadipate semialdehyde dehydrogenase, and a 3-aminoadipate deaminase. 
     
     
         49 . The non-naturally occurring microbial organism of  claim 48 , wherein said muconate pathway comprises a set of muconate pathway enzymes, set of muconate pathway enzymes selected from the group consisting of:
 A) (1) lysine aminotransferase, (2) lysine aminating oxidoreductase, (3) 2-aminoadipate semialdehyde dehydrogenase, (4) 2-aminoadipate deaminase, and (5) muconate reductase   B) (1) lysine-2,3-aminomutase, (2) 3,6-diaminohexanoate aminotransferase, (3) 3,6-diaminohexanoate aminating oxidoreductase, (4) 3-aminoadipate semialdehyde dehydrogenase, (5) 3-aminoadipate deaminase, and (6) muconate reductase.   
     
     
         50 . The non-naturally occurring microbial organism of  claim 49 , wherein said microbial organism comprises two exogenous nucleic acids each encoding a muconate pathway enzyme. 
     
     
         51 . The non-naturally occurring microbial organism of  claim 49 , wherein said microbial organism comprises three exogenous nucleic acids each encoding a muconate pathway enzyme. 
     
     
         52 . The non-naturally occurring microbial organism of  claim 49 , wherein said microbial organism comprises four exogenous nucleic acids each encoding a muconate pathway enzyme. 
     
     
         53 . The non-naturally occurring microbial organism of  claim 49 , wherein said microbial organism comprises five exogenous nucleic acids each encoding a muconate pathway enzyme. 
     
     
         54 . The non-naturally occurring microbial organism of  claim 49 , wherein said microbial organism comprises six exogenous nucleic acids each encoding a muconate pathway enzyme. 
     
     
         55 . The non-naturally occurring microbial organism of  claim 48 , wherein said at least one exogenous nucleic acid is a heterologous nucleic acid. 
     
     
         56 . The non-naturally occurring microbial organism of  claim 48 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium. 
     
     
         57 . A method for producing muconate, comprising culturing the non-naturally occurring microbial organism according to  claim 48 , under conditions and for a sufficient period of time to produce muconate. 
     
     
         58 .- 65 . (canceled) 
     
     
         66 . A semi-synthetic method for synthesizing terephthalate (PTA) comprising preparing muconic acid by culturing an organism of any one of claims,  2 ,  20 ,  34 , or  49 , reacting said muconic acid with acetylene to form a cyclohexadiene adduct, and oxidizing said cyclohexadiene adduct to form PTA. 
     
     
         67 . The method of  claim 66 , further comprising isolating muconic acid prior to reacting with acetylene. 
     
     
         68 . The method of  claim 66 , wherein the step of reacting said muconic acid with acetylene comprises adding acetylene to the culture broth. 
     
     
         69 . The method of  claim 68 , wherein the culture broth is filtered prior to adding acetylene. 
     
     
         70 . The method of  claim 68 , wherein said step of oxidizing said cyclohexadiene adduct comprises adding air or oxygen to the culture broth.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.